Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Candidates For The US FDA’s STAR Program Might As Well Be Breakthrough Therapies, Too
Jun 27 2022
•
By
Derrick Gingery
The FDA's requirements for the STAR program are very similar to the breakthrough therapy designation. • Source: Shutterstock
More from Review Pathways
More from Pathways & Standards